a a a 3
TRANSCRIPT
-
8/9/2019 A a a 3
1/20
MAHARASHTRA COLLEGE OF PHARMACY
APPLICATION OF cDNA MICROARRAY TECHNOLOGY IN CARCINOGEN IDENTIFICATION Page 1
INTRODUTION
A DNA microarray is a multiplex technology used in molecular biology
and in medicine.
Microarray technology evolved from southern blotting where
fragmented DNA is attached to a subtrateand then probed with a known
gene or fragment .
The basic principle underlying microarray technology is that
complementary nucleic acids will hybridize. Hybridization provides exquisite
selectivityof complementary stranded nucleic acids, with high sensitivityand
specificity. In the traditional techniques, in which radioactivelabeling
materials are usually used, the simultaneous hybridizationof test and
reference samples is impossible
DNA microarray technology has empowered the scientific community
to understanding the fundamental aspect underlying the growth and
development of life as well as to explore the genetic cause of anomalities
occurring in the functioning of the human body.
A typical microarray experiment involves the hybridization of an mRNA
molecule to the DNA template from which it is originated.
The advantages of the cDNA microarray comparedwith the
oligonucleotide array have been thought to includeless susceptibility and
higher specificity due to the longersequences of the targets .However,
cDNAmay contain repetitive sequences that are often observed invarious
-
8/9/2019 A a a 3
2/20
-
8/9/2019 A a a 3
3/20
-
8/9/2019 A a a 3
4/20
MAHARASHTRA COLLEGE OF PHARMACY
APPLICATION OF cDNA MICROARRAY TECHNOLOGY IN CARCINOGEN IDENTIFICATION Page 4
-
8/9/2019 A a a 3
5/20
MAHARASHTRA COLLEGE OF PHARMACY
APPLICATION OF cDNA MICROARRAY TECHNOLOGY IN CARCINOGEN IDENTIFICATION Page 5
3. Comparative Genomic Hybridization
-
8/9/2019 A a a 3
6/20
MAHARASHTRA COLLEGE OF PHARMACY
APPLICATION OF cDNA MICROARRAY TECHNOLOGY IN CARCINOGEN IDENTIFICATION Page 6
Principal of micro array technology;
-
8/9/2019 A a a 3
7/20
MAHARASHTRA COLLEGE OF PHARMACY
APPLICATION OF cDNA MICROARRAY TECHNOLOGY IN CARCINOGEN IDENTIFICATION Page 7
The basic principle underlying micro array technology is thatcomplementary
nucleic acids will hybridize. Hybridization provides exquisite selectivityof
complementary stranded nucleic acids, with high sensitivityand specificity. In
the traditional techniques, in which radioactive
labeling materials are usually
used, the simultaneous hybridizationof test and reference samples is
impossible
In micro array-basedtechnologies, the solid surface, such as a glass
slide, containshundreds to thousands of immobilized DNA (targets) spots
whichcan be simultaneously hybridized with two samples (probes) labeledwith
different fluorescent
-
8/9/2019 A a a 3
8/20
MAHARASHTRA COLLEGE OF PHARMACY
APPLICATION OF cDNA MICROARRAY TECHNOLOGY IN CARCINOGEN IDENTIFICATION Page 8
-
8/9/2019 A a a 3
9/20
MAHARASHTRA COLLEGE OF PHARMACY
APPLICATION OF cDNA MICROARRAY TECHNOLOGY IN CARCINOGEN IDENTIFICATION Page 9
-
8/9/2019 A a a 3
10/20
MAHARASHTRA COLLEGE OF PHARMACY
APPLICATION OF cDNA MICROARRAY TECHNOLOGY IN CARCINOGEN IDENTIFICATION Page 10
Applications include:
Technology or
ApplicationSynopsis
Gene expression
profiling
used to identify genes whose expression is
changed in response to pathogens or other
organisms by comparing gene expression in
infected to that in uninfected cells or tissues.
Chromatin
immunoprecipitation
on Chip
DNA sequences bound to a particular protein can
be isolated by immunoprecipitating that protein
these fragments can be then hybridized to a
microarray allowing the determination of protein
binding site occupancy throughout the genome.
SNP detection
microarrays make use of SNP detection, including
Genotyping, forensic analysis, measuring
predisposition to disease, identifying drug-
candidates, evaluating germline mutations in
individuals or somatic mutations in cancers,
assessing loss of heterozygosity, or genetic
linkage analysis.
-
8/9/2019 A a a 3
11/20
MAHARASHTRA COLLEGE OF PHARMACY
APPLICATION OF cDNA MICROARRAY TECHNOLOGY IN CARCINOGEN IDENTIFICATION Page 11
Gene expression:The sequence of a gene does not give information about its activity. A
gene must be transcribed into mRNA to be expressed (or turned ON). The
level of expression (or activity) of a gene can therefore be studied by
measuring how much corresponding mRNA is made (transcribed) from a
particular gene.
The sequence of a gene is complementary to the sequence of its mRNA.
Therefore the mRNA can base pair (or hybridize) to the DNA strand it was
copied from (template strand). Scientists study gene expression by
measuring the amount of mRNA for different genes.
ALL of our cells contain the exact same DNA sequence. All cells arose
from a single cell (the egg). However different type of cells in the body
expresses different sets of genes. For example, a liver cell expresses some
of the same genes expressed in lung cells or skin cells but also expresses
genes that no other cell type expresses (liver-specific genes). As a result
liver cells look different from other cells in the body and do things that no
other cell can do.
Microarrays are simply a method for visualizing which genes are likelyto be used in a particular tissue at a particular time under a particular set
of conditions. The output of a microarray experiment is called a e gene
expressionprofile.
-
8/9/2019 A a a 3
12/20
-
8/9/2019 A a a 3
13/20
MAHARASHTRA COLLEGE OF PHARMACY
APPLICATION OF cDNA MICROARRAY TECHNOLOGY IN CARCINOGEN IDENTIFICATION Page 13
-
8/9/2019 A a a 3
14/20
MAHARASHTRA COLLEGE OF PHARMACY
APPLICATION OF cDNA MICROARRAY TECHNOLOGY IN CARCINOGEN IDENTIFICATION Page 14
-
8/9/2019 A a a 3
15/20
MAHARASHTRA COLLEGE OF PHARMACY
APPLICATION OF cDNA MICROARRAY TECHNOLOGY IN CARCINOGEN IDENTIFICATION Page 15
Drug Target:
DNA microarray which allows the monitoring of gene expression level of
thousands of genes simultaneously played a significant role in drug discovery.
Animals may not be fully predictive of the response in human due to
species variation. The pre-clinical studies in animals do not always detect
drugs that prove to be toxic in human. Ex. tacrine, used to treat patients
with Alzheimerds disease include hepatotoxicity by the elevation of liver
transminase in human, but there was no evidence of liver toxicity in mice
rats ordogs during pre-clinical development. Drug-inducedhepatotoxicity
andliverdamage cause significant morbidity andmortality andrepresent a
major challenge inthe area of drugdevelopment anddesign.
Microarray databases are built on the expression data from well
definedmarketedpharmaceuticals, classical chemical toxicants andfew
proprietary drugs. These compounds have well definedpharmacological action
andsome are rat andhuman specific, which result in data bases that are
useful for predicting toxicity duringdevelopment of toxicity.
Microarray can be usedto screen for changes in gene expression
following exposure of tumour cells to drugs either in culture or in patients
following treatment. Studies on this type may provide information on the
precise mechanism of action of the drug or couldlead to the identification
of early markers of drugresponse. For predicting the longer term clinical
response to drug treatment, microarry couldalso yieldinformation about
possible side effects, andidentify markers that, in clinical context, couldbe
usedto predicts possible adverse effect events.
-
8/9/2019 A a a 3
16/20
MAHARASHTRA COLLEGE OF PHARMACY
APPLICATION OF cDNA MICROARRAY TECHNOLOGY IN CARCINOGEN IDENTIFICATION Page 16
App
lication of Microaray:
y Use of Microarrays in Tissue Engineering, Phenotype Analysis, andMonitoring
y Microarray Application to Oral Biology and Mediciney Gene discoveryy Drug discovery and developmenty Toxicological researchy Tumour classificationy Tumour growgh and progressiony Disease diagnosisy Detection, identification, and characterization of food-borne
pathogens
y DNA microarrays are being analyzed to understand the innate immunesystem, including the cellular response to various bacterialendotoxins
y DNA microarraysare now being used to identify other genes that maybe regulatedin response to endotoxins, such as LPS, with the
ultimate hopeof providing new drug targets for sepsis With the use
of human umbilical vein endothelial cells as a model, investigators
foundvarious genes that appear to be regulated in response toLPS. Many
of the genes identified confirm already well-establishedLPS-
regulated genes, whereas a few may represent new gene targets
-
8/9/2019 A a a 3
17/20
MAHARASHTRA COLLEGE OF PHARMACY
APPLICATION OF cDNA MICROARRAY TECHNOLOGY IN CARCINOGEN IDENTIFICATION Page 17
y Microarray technology has also been used to monitor changes inmetabolic processes including aging
Challenges:The limited availability or complete absence of in vivo human data adds
additional challenges to the analysis of microarrays using comparative
genomics. In such an instance, the effects observed using in vivo animal
models and in vitro human data need to be projected to the effects in
humans. Hence, a challenge is to extrapolate from these limited studies
whole-body human effects while accounting for potentially not well-known
or wellunderstood nonlinearities.
y Lack of Appropriate Arraysy Lack of Comparable Studiesy Applications will encompass defining gene function;y Inferring functional networks and pathways;y Understanding how variation is distributed among individuals,
populations, and species;
-
8/9/2019 A a a 3
18/20
-
8/9/2019 A a a 3
19/20
-
8/9/2019 A a a 3
20/20
MAHARASHTRA COLLEGE OF PHARMACY
APPLICATION OF cDNA MICROARRAY TECHNOLOGY IN CARCINOGEN IDENTIFICATION Page 20
y Adams JC, Watt FM (1993). Regulation of development anddifferentiation by the extracellular matrix. Aharoni A, Keizer LCP,
Bouwmeester HJ, Sun Z, Huerta MA, Verhoeven HA, et al. (2000).
Identification of the SAAT gene involved in strawberry flavor
biogenesis by use of DNA microarrays.
y Alizadeh AA, Eisen MB, Davis ER, Ma C, Lossos IS, Rosenwald A, etal. (2000). Distinct types of diffuse large B-cell lymphoma identified
by gene expression profiling.
y Ashkenas J, Muschler J, Bissell MJ (1996). The extracellular matrix inepithelial biology: shared molecules and common themes in distant phyla.